# Ibrance

NDC: 63539-187
Generic name: palbociclib
Labeler / Manufacturer: U.S. Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20170508

FDA application: NDA207103

## Active ingredients

- PALBOCICLIB: 75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63539-187"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63539-187
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86718885-da44-4d3d-b3ca-06cbcedcffd8